HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons.

Abstract
Leech antiplatelet protein (LAPP) is a specific inhibitor of collagen-induced human platelet aggregation and adhesion to collagen under static conditions. Recombinant LAPP (rLAPP) and L-366,763 (acetylated-Cys-Asn-Pro-Arg-Gly-Asp-Cys-NH2), a peptidyl fibrinogen receptor antagonist, were evaluated in an anesthetized baboon thrombosis model using a collagen-coated graft segment of an arteriovenous shunt to elicit thrombus formation. Animals were randomized to receive systemic intravenous administration of rLAPP (100 micrograms.kg-1 x min-1; n = 5), L-366,763 (8.5 micrograms.kg-1 x min-1; n = 3), or saline (n = 3). Despite complete and selective inhibition of type I collagen-induced ex vivo aggregation of platelets, rLAPP had no significant effect on the rate or the extent of 111-In-labeled platelet deposition onto the collagen graft and no effect on template bleeding time. In contrast, L-366,763 completely prevented platelet deposition, maintained blood flow, and significantly prolonged bleeding time at the dosage that inhibited ex vivo aggregation in response to all agonists studied. In this study, the absence of an antithrombotic benefit of rLAPP contrasted sharply with the efficacy of the fibrinogen receptor antagonist. These results demonstrate that specific inhibition of collagen-mediated platelet aggregation alone is not sufficient to prevent platelet-dependent thrombosis in this baboon model.
AuthorsL W Schaffer, J T Davidson, P K Siegl, R J Gould, R F Nutt, S F Brady, T M Connolly
JournalArteriosclerosis and thrombosis : a journal of vascular biology (Arterioscler Thromb) Vol. 13 Issue 11 Pg. 1593-601 (Nov 1993) ISSN: 1049-8834 [Print] United States
PMID8218100 (Publication Type: Journal Article)
Chemical References
  • LAPP protein, Haementeria officinalis
  • Oligopeptides
  • Platelet Aggregation Inhibitors
  • Platelet Membrane Glycoproteins
  • Recombinant Proteins
  • Salivary Proteins and Peptides
  • L 366763
  • Fibrinopeptide A
  • Collagen
Topics
  • Amino Acid Sequence
  • Animals
  • Arteriovenous Shunt, Surgical
  • Bleeding Time
  • Collagen (pharmacology)
  • Fibrinopeptide A (metabolism)
  • Kinetics
  • Male
  • Molecular Sequence Data
  • Oligopeptides (pharmacology)
  • Papio
  • Partial Thromboplastin Time
  • Platelet Aggregation (drug effects)
  • Platelet Aggregation Inhibitors (pharmacology, therapeutic use)
  • Platelet Membrane Glycoproteins (antagonists & inhibitors)
  • Recombinant Proteins (administration & dosage, pharmacology, therapeutic use)
  • Salivary Proteins and Peptides (administration & dosage, pharmacology, therapeutic use)
  • Thrombosis (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: